GLENMEDE TRUST CO NA - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$212,000
+29.3%
3,982
-0.2%
0.00%0.0%
Q3 2020$164,000
-15.9%
3,988
-1.0%
0.00%0.0%
Q2 2020$195,000
-53.3%
4,028
-58.8%
0.00%
-50.0%
Q1 2020$418,0000.0%9,7810.0%0.00%0.0%
Q4 2019$418,000
+54.8%
9,781
+30.2%
0.00%
+100.0%
Q3 2019$270,000
+280.3%
7,515
+180.4%
0.00%
Q2 2019$71,000
-32.4%
2,680
-31.5%
0.00%
Q1 2019$105,000
+18.0%
3,915
-29.2%
0.00%
Q4 2018$89,000
+6.0%
5,530
+36.4%
0.00%
Q3 2018$84,000
+1300.0%
4,055
+1858.9%
0.00%
Q1 2018$6,0000.0%2070.0%0.00%
Q4 2017$6,000
-14.3%
2070.0%0.00%
Q3 2017$7,000
-50.0%
207
-58.6%
0.00%
Q4 2016$14,000
-6.7%
5000.0%0.00%
Q3 2016$15,000
-16.7%
500
-12.0%
0.00%
Q2 2016$18,000
+20.0%
5680.0%0.00%
Q1 2016$15,000
-11.8%
568
+13.6%
0.00%
Q4 2015$17,000
+6.2%
5000.0%0.00%
Q3 2015$16,000
-20.0%
5000.0%0.00%
Q2 2015$20,000
+25.0%
5000.0%0.00%
Q1 2015$16,000
+6.7%
5000.0%0.00%
Q4 2014$15,000
-37.5%
500
-50.0%
0.00%
Q3 2014$24,000
+9.1%
1,0000.0%0.00%
Q2 2014$22,000
-8.3%
1,0000.0%0.00%
Q1 2014$24,0000.0%1,0000.0%0.00%
Q4 2013$24,000
-11.1%
1,0000.0%0.00%
Q3 2013$27,000
+50.0%
1,0000.0%0.00%
Q2 2013$18,0001,0000.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
RA Capital Management 5,250,000$144,218,00015.05%
Baker Brothers Advisors 19,955,126$548,167,0007.79%
HARVEY CAPITAL MANAGEMENT INC 508,000$13,954,0007.08%
RA Capital Management 2,035,510$55,915,0005.84%
Bodri Capital Management, LLC 150,000$4,121,0002.40%
Cupps Capital Management, LLC 920,017$25,272,0001.64%
Perceptive Advisors 1,221,230$33,548,0001.38%
Geduld E E 80,000$2,198,0001.34%
Alkeon Capital Management 1,709,200$46,951,0000.92%
PALISADE CAPITAL MANAGEMENT, LP 1,205,651$33,119,0000.90%
View complete list of ACADIA PHARMACEUTICALS INC shareholders